chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lump in Neck; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK MASS (Lump in Neck) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced NECK MASS (Lump in Neck). At the time of the report, NECK MASS (Lump in Neck) had not resolved.            Action taken with mRNA-1273 in response to the events was not applicable.  Patient reported that concomitant medications are taken by her.  No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-101938 (Patient Link).
Shortly after taking the pfizer vaccine I suffered from blackout faint feelings off and on for more that 18  to 20 hours after taking this vaccine. server swelling of my entire body especially inside my head and  heart pains. I also,  suffered from episodes of  memory loss even now. Problems with my balance when walking....never ever suffered from anything like this in my entire life. this vaccine is extremely  dangerous and should not be given to everyone. nearly 19 hours later my face and feet  numb.
Headache the day of after several hours, Fever Chills Stomachache Fatigue after going to sleep.
Day 2:  severe headache, joint and muscle pain, extreme fatigue. Day 3: in addition to the first symptoms a red raised rash on neck, torso , back, and insides of arms, skin tingling and sensitivity, breast tenderness, pain in ovaries. Day 4: rash gone but skin sensitivity increased. Day 5-9: symptoms continued. Day 10:  stomach cramping with nausea. Day 11: symptoms continued and leg cramps began. Day 13: contacted doctor after pause was noted on J&J vaccine. Dr. DX'd inflammatory response to J&J vaccine and ordered bloodwork. Day 15: severe itching started all over body, with increased sensitivity and tingling (prickly feeling). Day 15-23: itching, tingling, pins and needles feelings in feet and hands, joint and muscle pain continue. Day 23: saw doctor again, steroids recommended and referral to a Rheumatologist for further tests.
My left foot felt like if itwas on fire, I went to the ER and said that I have gout, they gave me some medicine.
Injection site soreness; Swelling; Redness; Chills during period about 12-20 hours postinjection; low grade fever during period about 12-20 hours postinjection; Malaise; This is a spontaneous report from a non-contactable consumer (reported for herself). A 65-years-old elderly female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN5318) via an unspecified route of administration, administered in arm left on 28Jan2021 as Dose 2, single and received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EL3246 as Dose 1,Single for Covid-19 immunization at Hospital. Medical history included osteopenia and osteoporosis. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. On an unspecified date in Jan2021, the reporter stated that Injection site soreness, swelling, and redness, lasting a few days; chills during period about 12-20 hours postejection; low grade fever during period about 12-20 hours postejection, 38.2C at 20 hours; malaise lasting a few days. No treatment was given for the events. The patient underwent lab tests and procedures which included pyrexia: 38.2c centigrade on an unspecified date. The outcome of the events was recovered/resolved on an unspecified date in 2021.  No follow up attempts are possible. No further information is expected.
After first dose my face started peeling. I thought it was related to the mask I?ve been wearing and did t think much of it. It took 3 weeks to clear up but it did clear up completely for a week. I used gentle moisturizers only. I took the second dose on Wednesday 2/3/21 and I was off work the 3 days after that. I stayed home due to headache and body aches. Did not use ANY mask. On Friday my face started peeling again and continued to get worse on Saturday. It feels like a bad sunburn with very sensitive red skin. I?m using the same moisturizer. Nothing has changed.
he tested positive for covid on 30Dec2021 & his wife tested positive a couple of days prior; he tested positive for covid on 30Dec2021 & his wife tested positive a couple of days prior; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 80 year-old female patient received bnt162b2 (BNT162B2), administration date 28Feb2021 (Batch/Lot number: unknown) as dose 2, single and administration date 07Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Dec2021, outcome "unknown" and all described as "he tested positive for covid on 30Dec2021 & his wife tested positive a couple of days prior". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (08Jan2022) negative; (Dec2021) positive.  Clinical Course: he and his wife received the first Pfizer Covid 19 Vaccine on 07Feb2021. The second Pfizer Covid 19 Vaccine was received on 28Feb2021. Per caller he tested positive for covid on 30Dec2021 & his wife tested positive a couple of days prior roughly 10 days ago in Dec. Caller reports they both tested negative on 08Jan2022. They are scheduled to receive the Pfizer Covid 19 Booster on 12Jan2021. Caller asking if that will be to soon. Caller is a 79 year old male and his wife is an 80 year old female.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200036785 same reporter/drug/event, different patient.
Had a low grade temp, felt fatigued, and had headache on 4/28. 4/29 afternoon/evening temp was 104.2 oral had severe headache, chills and nausea. On 5/1 symptoms had improved and client had a low grade fever. Was given ibuprofen to help with symptoms from mother.
Pt's father brought in the pt to the clinic on 03/21/2002. The pt woke up on 03/20/2002 and told her mother "her arm was broken." On 03/22/2002 left arm bright red, swollen, child complained of pain and tenderness. I have not seen this type of post vaccine reaction from DTP.
Tenderness by touch at shot site for 2 days Red rash patch around shot site noticed on second day after shot and is still there after two weeks  Saw primary care physician 2/25/2021 and he said the rash could be a reaction to something in the shot.  He suggested I have the second shot (scheduled for 3/13/2021) in the other arm.
DOSE 1 ON MARCH 16, 2021 DOSE 2 ON APRIL 13, 2021 SEVERE PAIN STIFFNESS, TETANUS, ACHES, FATIGUE, MORE PAIN SAME DAY FOLLOWING FIRST INJECTION...MUMPS-LIKE SYMPTOMS...PAIN FROM INJECTION SITE, UP NECK, BACK OF HEAD...TOTALLY DEBILITATING PAIN WORSE IN EVENINGS AND PAIN "MOVING" FROM ARM TO NECK TO HEAD AND BACK...WORSE AT NIGHT...SAME SYMPTOMS WITH EACH DOSE...2 MONTHS NOW! PAIN LASTED 4 WEEKS AND WAS REMITTING AT TIME OF SECOND INJECTION SEVERE PAIN STIFFNESS, TETATNUS, ACHES, FATIGUE, MORE PAIN SAME DAY FOLLOWING SECOND INJECTION (I WAS ALMOST BETTER AND THEN BACK TO WORSE THAN FIRST DOSE) WAY WORSE! PAIN LASTED 4 WEEKS AND IS CONTINUING NOW.... about 8 or 9 weeks total so far. Have been seeking medical attention and getting no relief or help. Family doctor is not attentive or knowledgeable. Checking into Emergency Room tomorrow ... will provide this info to them. Please send PERMANENT Report Number and advise.  Please help me.
Headaches; Light sensitivity; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 14:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included illness, the patient developed a strange illness a few years ago, suffered health concerns since and penicillin allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 16:00, the patient experienced headaches, also had some light sensitivity and dizziness. It had been over a week and the patient continued to have headaches. It does not seem like the headaches were stopping. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headaches, light sensitivity and dizziness were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Scheduled repeat c-section on 3/9/2022. Newborn weighs 7 lb 8.3 oz. Hospital admission within 6 weeks of receiving the COVID vaccine.
itching at injection site and rest of arm; treated with Benadryl 25mg x1; improved
PATIENT WAS GIVEN MMR AND VARICELLA LIVE VACCINES IN PREGNANCY. wILL HAVE TO MONITOR TO DETERMINE ADVERSE EVENT
Within approximately 30 minutes from TDAP administration, at approximately 8:15 am, patient experienced lightheadedness, dizziness, nausea, dry heaving, appeared pale per coworkers. Patient work for the day, declined need for medical evaluation. Per patient, all symptoms appeared resolved by 12 pm on date of administration.
She also shared with agent that she previously had an allergic reaction with the Pfizer-BioNTech COVID-19 Vaccine.; The first vaccine made her feel a little bad; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 (Lot number: EN6198) at the age of 67 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (ongoing); "trouble walking" (unspecified if ongoing); "arthritis" (unspecified if ongoing). Family history included: "heart failure" (unspecified if ongoing), notes: Husband; "Multiple Sclerosis" (unspecified if ongoing), notes: daughter. There were no concomitant medications. Vaccination history included: Flu vaccine (Location: right arm). The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "The first vaccine made her feel a little bad"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "She also shared with agent that she previously had an allergic reaction with the Pfizer-BioNTech COVID-19 Vaccine."  Additional information: The first vaccine made her feel a little bad, but nothing like the second vaccine. She has fibromyalgia, and has a lot of pain anyway and she doesn't know whether there is any information about patients with Fibromyalgia, and the vaccine hitting them harder and laid in bed for 2 days. She was in so much pain that she couldn't move.She had hydrocodone pain medicine for her Fibromyalgia.She thinks her first dose was on 25Mar2021 she did get it in her left arm. No follow-up attempts are possible. No further information is expected.
100° temp today / How long does the fever last; This case was reported by a consumer via call center representative and described the occurrence of fever in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On 7th January 2021, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix and experienced fever (100 degree fahrenheit). The patient was asking how long will the fever last. No further information was provided.
Patient received TDAP AND meningococcal vaccines. Waited for 15 minutes after vaccine. Pt was fine when released. Mother discussing insurance with facility workers and suddenly pt fell back/fainted. His skin became pale and his body became stiff. It seemed as if he may have had a brief seizure for about 10-15 seconds (maybe shorter) (the parent seemed to think he was also having a seizure), and he then started to become conscious again. Once conscious the pt felt weak, but knew his surroundings, name, dob etc. He then was taken to the School Nurse for further evaluation. When falling, the student did seem that he may have hit his head on the wall when falling backward. Vaccines administered at a prescheduled school vaccination event. LVN was present as well as School Nurse, and three Medical Assistants to assist with incident.
Call from mom, states 1/11/00 child had fever 2 hours after vaccine, decreased appetite. 1/13/00 - broke out in blisters on head, ears, bac, bottom, underarms. Child had fever, crying, fussy.  Cousin had Chicken pox 17 days ago.
seen on 7JAN93 for well visit; looked fine on PE; no hx of any prev adverse reaction; approx 12 hrs later had fever to 102.7 & 3 poss apneic episodes; also severe local reaction, tenderness, swelling;
Diarrhea started on night of May 6. After about an hour of going to and fro toilet, the color red started appearing in stool. After several times, there was no brown and just bright red substance.
Fever to 38.8C, moderate muscle pain, severe fatigue Slight soreness at injection site
Patient reported feeling nauseated and went to bathroom, patient felt dizzy and appeared diaphoretic Patient found by staff and seen by medical team, vitals were stable, and patient stated symptoms improved and provided snack and water Patient refused medical transport and signed AMA form Patient driven home by grandmother
Slept for two days; a lot of pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSOMNIA (non-serious), outcome "unknown", described as "Slept for two days"; PAIN (non-serious), outcome "unknown", described as "a lot of pain".  Additional Information: The patient reported to have a "hard time" with the vaccine and couldn't even get out of bed. The patient did not quite know what was to be done.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
- can't move arm "frozen shoulder" - pain radiates from neck to fingertips - numbness in left hand - bruising high up on deltoid - no relief from ibuprofen or Tylenol
For the first few days it was not too bad but now it is tender, warm. Cannot tell if it is swollen or red. Cannot use it to drive. Cannot lift it.
First dose 2 years ago. Didn't get second dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose, 2 years ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule.
Yesterday, I took 20,000 steps and my second shot feels like I'm on a caffeine buzz of energy.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Apr2021 10:00 (Lot number: Er8727) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "HBP" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: PROPOFOL; PROZAC; LISINOPRIL. The following information was reported: ENERGY INCREASED (non-serious) with onset 01Apr2021 12:00, outcome "not recovered", described as "Yesterday, I took 20,000 steps and my second shot feels like I'm on a caffeine buzz of energy."; WEIGHT INCREASED (non-serious), outcome "unknown", described as "My leg skin is starting to sag from losing weight quickly". Therapeutic measures were not taken as a result of energy increased.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist refers to unspecified number of patients of unknown age. On an unknown date an unspecified number of unspecified patients might have received doses of ZOSTAVAX (lot#, dose and route not reported) that were transported at unspecified temperatures outside of the prescribing information for an unspecified length of time. No adverse effects were reported. It was unspecified if the patient's had sought medical attention. Additional information has been requested.
Large raised painful red bump on arm.  About 1? from injection site but not on it. Continues to grow larger.
This spontaneous report was received from a Nurse refers to a patient of an unknown age and gender. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On 01-SEP-2016, the patient was vaccinated with an improperly stored dose of M-M-R II lot # L049316 (expiry date: 03-DEC-2017). No adverse reactions reported. No Product Quality Complain (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Headache; chills; 101.2 temperature; This is a spontaneous report from a Pfizer-sponsored program SUPPORT from a contactable consumer (reported for herself). A female patient of an unspecified age received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 15Mar2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. On 16Mar2021, the patient experienced headache, chills and 101.2 temperature. The patient underwent lab tests and procedures which included body temperature: 101.2 on 16Mar2021. The consumer requesting to know if she can take Tylenol now that it has been 24 hours after second dose. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
After receiving COVID-19 product Moderna NDC 80777-0275-99 RX team and RPh were under the impression this product was to be used for booster doses. After due diligence, it was found to be this patient may have received 0.25mL of the product (rather than the recommended 0.5mL dose for boosters). I will then contact the patient's physician to see if they would like us to repeat the dose.
Erythema of Rt anterior arm w/ swelling and tenderness that goes into Rt shoulder. Taking Tylenol and motrin currently.
PFIZER-BIONTECH COVID-19 VACCINE EUA. PATIENT RECEIVED FIRST DOSE OF VACCINE ON 2/8/21.  PATIENT REPORTEDLY PASSED AWAY ON 2/13/21 AT 7AM IN NURSING FACILITY.  Record of death states CHF as principle cause of death and Stage IV CKD as contributory cause of death.
Within the first 5 minutes of injection: heart palpitations, shortness of breath, dizziness, extreme thirst, and facial numbness.
Fever & NauseaVomiting Narrative:  employee health recommended prompt care for nausea medications but pt decided to try OTC and improved; felt like morning sickness while she was pregnant
Severe shakes & chills, Sore throat, Mild headache, Severe backache - To bed
approx 27mos p/vax pt devel varicella. pt seen by MD 24nov & lesions were gone
Patient reported symptoms of nausea, vomiting, and dizziness. Symptom onset date reported as 11/10/10. Symptoms lasted x 24 hrs.
This is a spontaneous report from a contactable physician via representative and from a contactable pharmacist. A 18 year old female patient received first single dose  TRUMENBA (lot J29203, expiry date JUN2016) on 05MAY2015. Medical history and concomitant medications were not provided. The patient experienced vomiting, limited arm movement, body weakness, swelling of arm, pain and swollen lymph under arms on unknown date. THe events did not require an emergency room or physician visit or hospitalization. No specific tests and/or treatment were required. The physician wanted to know information about the immune response after the first dose because the patient did not want to receive the succeeding shots because of these reactions. Events outcome was not provided. Causality assessment was unknown. Follow-up (19JUN2015): New information from a contactable pharmacist includes: vaccine dose number, lot number, expiry date,, vaccination date, additional event.
50mm reddened, swollen, hard area on arm, very hot to the touch right arm.  Also itching at site.  Recommended cool wash cloth, ibuprofen and Benadryl.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 15-DEC-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # L002310, expiration date 08-JUL-2016) (dose and route not reported). The temperature and time of excursion was 1.11 degrees C for 208 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Patient states his left hand became and has stayed extremely swollen 2 weeks after covid booster vaccine-Severe, Additional Details: Patient's left hand is very swollen. He states it became that way 2 weeks after he received his booster shot and has stayed that way for 3 weeks now. He went to the ER, they treated him with ice packs and a wrap but it hasn't resolved. He states he has an appointmetn with his PCP on Wed 11/24/21 to discuss.